Cerecor Appoints Simon Pedder to its Board of Directors

BALTIMORE, MD — (Marketwired) — 04/09/18 — Cerecor, Inc. (NASDAQ: CERC), today announced that Simon C. Pedder, Ph.D. has been appointed to its Board of Directors.
“We are delighted to welcome Dr. Pedder to our Board.” said Dr. Uli Hacksell, Chairman of the Board of Cerecor, “With his experience in all stages of drug development and collaborating with the FDA on several products leading to approval, Dr. Pedder is a key addition for the Company. He will provide valuable insights and strategic guidance as we continue to develop our innovative compounds.”

This entry was posted in Recent Development News: Q2 - 2018, Recent Developments. Bookmark the permalink.
Read Full Article »